Xenon Pharmaceuticals XENE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's total operating expenses?
- Xenon Pharmaceuticals (XENE) reported total operating expenses of $112.33M in Q1 2026.
- How has Xenon Pharmaceuticals's total operating expenses changed year-over-year?
- Xenon Pharmaceuticals's total operating expenses increased by 40.0% year-over-year, from $80.24M to $112.33M.
- What is the long-term trend for Xenon Pharmaceuticals's total operating expenses?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's total operating expenses has grown at a 40.6% compound annual growth rate (CAGR), from $97.43M to $380.57M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.